Literature DB >> 7780954

A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.

R A Herbst1, A Larson, J Weiss, W K Cavenee, G M Hampton, K C Arden.   

Abstract

Karyotypic and molecular data indicate that genetic alterations of the long arm of chromosome 11 (11q) may be involved in malignant melanoma. To test this we analyzed 5 polymorphic microsatellite repeats on 11q using a PCR-based assay for loss of heterozygosity in normal and tumor tissues from 24 individuals with cutaneous malignant melanoma of various stages. Our findings indicate that a tumor suppressor gene that plays a role in malignant melanoma is located on the long arm of chromosome 11, likely within a 51 cM region at 11q23. Its loss appears to be a late event in tumor progression and may serve as an indicator for a less favorable clinical outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780954

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  ei24, a p53 response gene involved in growth suppression and apoptosis.

Authors:  Z Gu; C Flemington; T Chittenden; G P Zambetti
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter.

Authors:  W W Noll; D R Belloni; J L Rutter; C A Storm; A R Schned; L Titus-Ernstoff; M S Ernstoff; C E Brinckerhoff
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

Review 4.  Liquid Biopsies for Assessing Metastatic Melanoma Progression.

Authors:  Kelly Huynh; Dave S B Hoon
Journal:  Crit Rev Oncog       Date:  2016

5.  Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.

Authors:  Aimee M Crago; Nicholas D Socci; Penelope DeCarolis; Rachael O'Connor; Barry S Taylor; Li-Xuan Qin; Cristina R Antonescu; Samuel Singer
Journal:  Clin Cancer Res       Date:  2012-01-12       Impact factor: 12.531

6.  Molecular clonality of in-transit melanoma metastasis.

Authors:  T Nakayama; B Taback; R Turner; D L Morton; D S Hoon
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

7.  Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23.

Authors:  B E Baysal; J E Farr; W S Rubinstein; R A Galus; K A Johnson; C E Aston; E N Myers; J T Johnson; R Carrau; S J Kirkpatrick; D Myssiorek; D Singh; S Saha; S M Gollin; G A Evans; M R James; C W Richard
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

Review 8.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide.

Authors:  Christina N Mork; Douglas V Faller; Remco A Spanjaard
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

10.  Risk of breast cancer not increased in translocation 11;22 carriers: analysis of 80 pedigrees.

Authors:  Melissa T Carter; Nicholas J Barrowman; Stephanie A St Pierre; Beverly S Emanuel; Kym M Boycott
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.